Scarica l'app Stockscreener
15.95
2.05%
0.32
Dopo l'orario di chiusura:
15.87
-0.08
-0.50%
Greenwich Lifesciences Inc Borsa (GLSI) Ultime notizie
What’s Driving GLSI Stock Today? - Stocktwits
Why Did GLSI Stock Rise Pre-Market Today? - Stocktwits
One Greenwich LifeSciences Insider Raised Their Stake In The Previous Year - simplywall.st
Understanding the Setup: (GLSI) and Scalable Risk - Stock Traders Daily
Why is Greenwich LifeSciences stock rallying today? - Investing.com
Greenwich (GLSI) Earnings Check: EPS Misses Its Estimate under the Current Snapshot; Post-Earnings Trading: The Share Price Sheds 0.69% on the DayAnnual Financial Report - vinanet.vn
Greenwich Lifesciences Inc (NASDAQ: GLSI) Share Price, GLSI Stock News, GLSI Share Price & Updates - Kalkine
Greenwich Lifesciences Stock Price Forecast. Should You Buy GLSI? - StockInvest.us
GLSI Q1 2026 Earnings: Wider-than-Expected Loss Reflects Clinical-Stage R&D InvestmentEarnings Revision Downgrade - vinanet.vn
Greenwich Lifesciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Greenwich LifeSciences (NASDAQ:GLSI) Posts Quarterly Earnings Results - MarketBeat
Greenwich LifeSciences 2Q 2026: Revenue $0 Net loss $(3.95M), EPS $(0.27) — 10-Q Summary - TradingView
Greenwich LifeSciences | 10-Q: Q2 2026 Earnings Report - Moomoo
Greenwich LifeSciences, Inc. (GLSI) stock price, news, quote and history - Yahoo Finance Singapore
Greenwich LifeSciences (GLSI) posts higher H1 2026 loss and flags going concern risk - Stock Titan
Greenwich Lifesciences Inc expected to post a loss of 33 cents a shareEarnings Preview - TradingView
Responsive Playbooks and the GLSI Inflection - Stock Traders Daily
Greenwich LifeSciences Extends Insider and Pre-IPO Share Lock-Up to January 31, 2027 - Quiver Quantitative
Greenwich LifeSciences Directors, Officers Face 100% Lock-Up to 2027 - Stock Titan
Greenwich LifeSciences (GLSI) Expected to Post Earnings on Thursday - MarketBeat
GLSI|Greenwich Lifesciences Inc|Price:13.400|Chg%:-0.100 - TradingKey
Form 4 Greenwich Lifesciences Inc For: 30 July By Investing.com - Investing.com Nigeria
Greenwich LifeSciences CEO Snehal Patel buys $29,555 in stock By Investing.com - Investing.com Nigeria
Greenwich LifeSciences CEO Snehal Patel buys $20,430 in shares By Investing.com - Investing.com UK
Form 4 Greenwich Lifesciences Inc For: 29 July By Investing.com - Investing.com Canada
Greenwich LifeSciences CEO Snehal Patel buys $20,430 in shares - Investing.com
Greenwich LifeSciences, Inc. (GLSI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Greenwich LifeSciences (NASDAQ:GLSI) CEO Snehal Patel Purchases 2,500 Shares - MarketBeat
Greenwich Lifesciences Inc (GLSI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
GLSI|Greenwich Lifesciences Inc|Price:13.470|Chg%:+0.490 - TradingKey
Form 4 Greenwich Lifesciences Inc For: 27 July By Investing.com - Investing.com Nigeria
Greenwich LifeSciences CEO buys $47,018 in company stock By Investing.com - Investing.com Canada
Greenwich LifeSciences CEO buys $47,018 in company stock - Investing.com
Greenwich LifeSciences (NASDAQ: GLSI) CEO adds 3,600 shares in open-market buys - Stock Titan
Greenwich LifeSciences, Inc. Revenue Breakdown – NASDAQ:GLSI - TradingView
Greenwich Lifesciences Inc (GLSI) Cash Flow - TradingKey
TradingKey - TradingKey
Greenwich Lifesciences Inc (GLSI) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Greenwich Lifesciences Inc (GLSI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Greenwich Lifesciences Inc (GLSI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Greenwich Lifesciences Inc (GLSI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Greenwich Lifesciences Inc (GLSI) Institutional Confidence - TradingKey
Greenwich LifeSciences (GLSI) Eases 1.6% as Key Support Level Comes Into FocusStop Hunt - vinanet.vn
HC Wainwright Issues Optimistic Forecast for GLSI Earnings - MarketBeat
Greenwich LifeSciences adds up to 10 UK trial sites - grafa.com
Greenwich LifeSciences gains UK approval for breast cancer trial By Investing.com - Investing.com South Africa
Greenwich LifeSciences Gets UK Clearance to Expand Breast Cancer Trial - Moomoo
Greenwich LifeSciences gains UK approval for breast cancer trial - Investing.com
Greenwich LifeSciences secures regulatory approval to expand FLAMINGO-01 trial into United Kingdom - Traders Union
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):